Clinical Trial

Lymphedema Evaluation After Adjuvant Hypofractionated Radiotherapy for 1-2 Macrometastatic Sentinel Lymph Nodes

Study acronym: AXILL-ART
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 20, 2024 (before its estimated December 31, 2024 completion). Its status may not reflect the trial's current state.
Summary
In this observational prospective studi patients with invasive breast cancer no more than 5 cm and clinically node negative, scheduled for conservative surgery and Sentinel Node Biopsy (SNB), are enrolled in the protocol if they have 1-2 sentinel lymphnodes (SLNs) with macrometastases. SLN status will be checked on definitive sections.
Trial Details
NCT Number NCT06321653
Lead Sponsor European Institute of Oncology
Conditions Arm Lymphedema, Breast Cancer, Radiotherapy Side Effect
Enrollment 120 participants
Start Date 2019-04-18
Primary Completion 2024-12-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-03-20